BIOX logo

Bioceres Crop Solutions (BIOX)

Profile

Full Name

Bioceres Crop Solutions Corp.

Ticker Symbol

BIOX

Exchange

NASDAQ

Sector

Basic Materials

Industry

Agricultural Inputs

Country

Argentina

IPO

March 22, 2018

Indexes

Not included

Website

http://investors.biocerescrops.com

Employees

400

Key Details

Price

$4.09(-1.45%)

Market cap

$247.25M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$464.83M(+10.82% YoY)

Annual EPS

$0.05(-82.81% YoY)

PE ratio

288.03

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.09
BIOX price is $4.09

30-Day Relative Volume

0.32
BIOX 30-day relative volume is 0.32

Price Performance

Price Today change

-1.45%
BIOX price is down -1.45% today

Price YTD change

-32.73%
BIOX price is down -32.73% since January 1st

Price 1-year change

-67.41%
BIOX price is down -67.41% year-on-year

Price 3-year change

-66.88%
BIOX price is down -66.88% over the past 3 years

Price Range

Price All-time high

$17.94
BIOX price is currently -77.20% below its historical high of $17.94

Price 3-year low

$3.51
BIOX price is currently +16.52% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$247.25M
BIOX market capitalization is $247.25 million

Market cap 3-year change

-56.77%
BIOX market capitalization is down -56.77% over the past 3 years

Market cap All-time high

$945.87M
BIOX market capitalization is currently -73.86% below its historical high of $945.87 million

Market cap sector rank

31.46%
BIOX market capitalization is higher than 31.46% of companies in Basic Materials sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.22%
BIOX shares outstanding is down -0.22% year-on-year

Shares Outstanding 3-Year Change

+30.54%
BIOX shares outstanding is up +30.54% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.65
BIOX beta is 0.65

200-day SMA

$7.45
BIOX price is currently -45.10% below its 200-day simple moving average

50-day SMA

$4.81
BIOX price is currently -14.94% below its 50-day simple moving average

RSI

43.16
BIOX 14-day relative strength index is 43.16

Volume

0.32
BIOX 30-day relative volume is 0.32

ATR

$0.40
BIOX average true range is $0.40

10-day Historical Volatility

88.45%
BIOX 10-day historical volatility is 88.45%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$464.83M
BIOX annual revenue is $464.83 million

Revenue Analysts estimate

$382.35M
BIOX annual revenue is currently +21.57% higher than the consensus analysts' forecast

Revenue 1-year change

+10.82%
BIOX annual revenue is up +10.82% year-on-year

Revenue Sector rank

34.36%
BIOX annual revenue is higher than 34.36% of companies in Basic Materials sector

EPS

EPS

$0.05
BIOX annual earnings per share is $0.05

EPS Analysts estimate

-$0.11
BIOX annual earnings per share is currently -146.45% lower than the consensus analysts' forecast

EPS 1-year change

-82.81%
BIOX annual earnings per share is down -82.81% year-on-year

EPS Sector rank

49.63%
BIOX annual earnings per share is higher than 49.63% of companies in Basic Materials sector

Profit

Gross profit

$182.43M
BIOX annual gross profit is $182.43 million

Gross margin

39.25%
BIOX annual gross profit margin is 39.25%

Operating profit

$41.52M
BIOX annual operating income is $41.52 million

Operating margin

8.93%
BIOX annual operating profit margin is 8.93%

Net income

$3.24M
BIOX annual net profit is $3.24 million

Net margin

0.70%
BIOX annual net profit margin is 0.70%

Expenses

Total expenses

$423.30M
BIOX annual total expenses is $423.30 million

Operating expenses

$140.91M
BIOX annual total operating expenses is $140.91 million

Cost of goods sold

$282.40M
BIOX annual cost of goods sold is $282.40 million

Selling, general & administrative expenses

$94.27M
BIOX annual SGA is $94.27 million

Depreciation and amortization

$21.30M
BIOX annual depreciation & amortization is $21.30 million

Interest expense

$24.12M
BIOX annual interest expense is $24.12 million

Income tax

$3.78M
BIOX annual income tax is $3.78 million

EBIT & EBITDA

EBIT

$34.16M
BIOX annual earnings before interest & taxes is $34.16 million

EBITDA

$55.46M
BIOX annual EBITDA is $55.46 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$850.63M
BIOX annual total assets is $850.63 million

Non current assets

$449.30M
BIOX annual long term assets is $449.30 million

Current assets

$419.50M
BIOX annual total current assets is $419.50 million

Cash and cash equivalents

$44.20M
BIOX annual cash & cash equivalents is $44.20 million

Accounts receivable

$207.32M
BIOX annual accounts receivable is $207.32 million

Inventory

$126.22M
BIOX annual inventory is $126.22 million

Liabilities

Total liabilities

$501.06M
BIOX annual total liabilities is $501.06 million

Long term liabilities

$192.70M
BIOX annual total long term liabilities is $192.70 million

Current liabilities

$327.30M
BIOX annual total current liabilities is $327.30 million

Accounts payable

$168.10M
BIOX annual accounts payable is $168.10 million

Debt

Total debt

$270.18M
BIOX annual total debt is $270.18 million

Total debt 1-year change

+4.96%
BIOX annual total debt is up +4.96% year-on-year

Long term debt

$131.08M
BIOX annual long term debt is $131.08 million

Short term debt

$139.10M
BIOX annual short term debt is $139.10 million

Equity & Capital

Shareholders equity

$314.26M
BIOX annual stockholders equity is $314.26 million

Book value

$314.00M
BIOX annual book value is $314.00 million

Retained earnings

-$10.66M
BIOX annual retained earnings is -$10.66 million

Working capital

$79.16M
BIOX annual working capital is $79.16 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$41.72M
BIOX annual cash flow from operations is $41.72 million

Cash from operations 1-year change

+1511.43%
BIOX annual cash flow from operations is up +1511.43% year-on-year

Cash from investing

-$28.73M
BIOX annual cash flow from investing activities is -$28.73 million

Cash from investing 1-year change

-11.67%
BIOX annual cash flow from investing activities is down -11.67% year-on-year

Cash from financing

-$10.06M
BIOX annual cash flow from financing activities is -$10.06 million

Cash from financing 1-year change

-130.51%
BIOX annual cash flow from financing activities is down -130.51% year-on-year

CAPEX

CAPEX

$22.78M
BIOX annual capital expenditures is $22.78 million

CAPEX 1-year change

+0.97%
BIOX annual capital expenditures is up +0.97% year-on-year

Free Cash Flow

Free cash flow

$18.93M
BIOX annual free cash flow is $18.93 million

Free cash flow 1-year change

+194.79%
BIOX annual free cash flow is up +194.79% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

39.25%
BIOX annual gross profit margin is 39.25%

Operating margin

8.93%
BIOX annual operating profit margin is 8.93%

Net margin

0.70%
BIOX annual net profit margin is 0.70%

ROA & ROE

ROA

0.39%
BIOX annual return on assets is 0.39%

ROE

0.95%
BIOX annual return on equity is 0.95%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

288.03
BIOX price to earnings ratio is 288.03

PE ratio Sector rank

100%
BIOX price to earnings ratio is higher than 100% of companies in Basic Materials sector

PB Ratio

PB ratio

0.80
BIOX price to book ratio is 0.80

PB ratio Sector rank

28.2%
BIOX price to book ratio is higher than 28.2% of companies in Basic Materials sector

PS Ratio

PS ratio

0.61
BIOX price to sales ratio is 0.61

PS ratio Sector rank

29.7%
BIOX price to sales ratio is higher than 29.7% of companies in Basic Materials sector

Enterprise value

Enterprise value

$503.72M
BIOX enterprise value is $503.72 million

Enterprise value Sector rank

40.15%
BIOX enterprise value is higher than 40.15% of companies in Basic Materials sector

EV/EBITDA

EV/EBITDA

12.16
BIOX EV/EBITDA is 12.16

EV/EBITDA Sector rank

76.95%
BIOX EV/EBITDA is higher than 76.95% of companies in Basic Materials sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.24
BIOX annual current ratio is 1.24

Quick ratio

0.90
BIOX annual quick ratio is 0.90

Leverage

Debt to equity

0.83
BIOX annual debt to equity ratio is 0.83

Interest coverage ratio

1.42
BIOX annual interest coverage ratio is 1.42

Risk & Stability

Piotroski F-Score

7
BIOX piotroski f-score is 7

Altman Z-Score

1.07
BIOX altman z-score is 1.07

Analyst ratings

Recent major analysts updates

Feb 13, 25 Canaccord Genuity
Buy
Feb 7, 25 Lake Street
Buy
Feb 7, 25 Canaccord Genuity
Buy
Jan 28, 25 Oppenheimer
Outperform
Nov 13, 24 Canaccord Genuity
Buy
Oct 21, 24 Oppenheimer
Outperform
Oct 17, 24 Canaccord Genuity
Buy
Sep 11, 24 Roth MKM
Buy
Sep 11, 24 Oppenheimer
Outperform
Sep 11, 24 Lake Street
Buy

Institutional Ownership

Similar stocks

HDSN logo
Hudson Technologies (HDSN)
UAMY logo
United States Antimony (UAMY)
GROY logo
Gold Royalty (GROY)
ASM logo
Avino Silver & Gold Mines (ASM)
GEVO logo
Gevo (GEVO)
GPRE logo
Green Plains (GPRE)
MTA logo
Metalla Royalty & Streaming (MTA)
IAUX logo
i-80 Gold (IAUX)
SLI logo
Standard Lithium (SLI)
  • What is the ticker symbol for Bioceres Crop Solutions?
  • Does Bioceres Crop Solutions pay dividends?
  • What sector is Bioceres Crop Solutions in?
  • What industry is Bioceres Crop Solutions in?
  • What country is Bioceres Crop Solutions based in?
  • When did Bioceres Crop Solutions go public?
  • Is Bioceres Crop Solutions in the S&P 500?
  • Is Bioceres Crop Solutions in the NASDAQ 100?
  • Is Bioceres Crop Solutions in the Dow Jones?
  • When was Bioceres Crop Solutions's last earnings report?
  • When does Bioceres Crop Solutions report earnings?
  • Should I buy Bioceres Crop Solutions stock now?

What is the ticker symbol for Bioceres Crop Solutions?

The ticker symbol for Bioceres Crop Solutions is NASDAQ:BIOX

Does Bioceres Crop Solutions pay dividends?

No, Bioceres Crop Solutions does not pay dividends

What sector is Bioceres Crop Solutions in?

Bioceres Crop Solutions is in the Basic Materials sector

What industry is Bioceres Crop Solutions in?

Bioceres Crop Solutions is in the Agricultural Inputs industry

What country is Bioceres Crop Solutions based in?

Bioceres Crop Solutions is headquartered in Argentina

When did Bioceres Crop Solutions go public?

Bioceres Crop Solutions's initial public offering (IPO) was on March 22, 2018

Is Bioceres Crop Solutions in the S&P 500?

No, Bioceres Crop Solutions is not included in the S&P 500 index

Is Bioceres Crop Solutions in the NASDAQ 100?

No, Bioceres Crop Solutions is not included in the NASDAQ 100 index

Is Bioceres Crop Solutions in the Dow Jones?

No, Bioceres Crop Solutions is not included in the Dow Jones index

When was Bioceres Crop Solutions's last earnings report?

Bioceres Crop Solutions's most recent earnings report was on Feb 12, 2025

When does Bioceres Crop Solutions report earnings?

The next expected earnings date for Bioceres Crop Solutions is May 14, 2025

Should I buy Bioceres Crop Solutions stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page